PsyAccess
Spravato®Registry-verifiedDesignated-centers model

Psychiatrie Kantonsspital Glarus

Glarus, Switzerland

Treatment & access

  • Treatments offeredesketamine (Spravato)
  • Access routepublic_reimbursed
  • Price informationReimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 55 646 41 00
  • Websitehttps://pdgl.ch

About this provider

Psychiatric care in the canton of Glarus, listed by the BAG under Kantonsspital Glarus, is provided since 1 July 2025 by the newly founded Psychiatrische Dienste Glarus (pdgl) at Burgstrasse 99 in Glarus, on the cantonal hospital campus. pdgl describes itself as the canton's integrated psychiatric basic-care provider, offering outpatient, day-clinic and inpatient treatment for adults plus child and adolescent services. Round-the-clock emergencies run through the Kantonsspital Glarus emergency unit (+41 55 646 33 33).

Services & programs

  • Adult outpatient clinic (Ambulatorium Erwachsene)
  • Day clinic for adults
  • Inpatient psychiatric ward (Station)
  • Outpatient psychiatric nursing at home (Ambulante psychiatrische Pflege, APP)
  • Child and adolescent psychiatric service (KJPD) with outpatient clinic
  • Counselling services and prevention offers
  • 24-hour emergencies via the Kantonsspital Glarus emergency unit

Common questions

The BAG list names Kantonsspital Glarus - who actually provides treatment now?

Since 1 July 2025, psychiatry in the canton of Glarus is run by the Psychiatrische Dienste Glarus (pdgl), which took over the services previously organised under Kantonsspital Glarus. Contact the pdgl secretariat (sekretariat@pdgl.ch, +41 55 646 41 00) for questions and registration.

What are the Swiss reimbursement conditions for Spravato here?

Esketamine nasal spray is reimbursed by basic insurance (OKP) only at BAG-designated centres, for adults 18-74 with treatment-resistant depression after at least two adequate antidepressant trials plus one augmentation attempt, with CGI-S of 5 or higher, prior insurer approval (Kostengutsprache) and a maximum treatment duration of 10 months.

Looking at alternatives? One of the BAG-designated Spravato centers; see the country guide and the limited-medical-use PAT program.

Verification

This record was taken directly from an official registry or program list and is re-checked on a rolling cadence.

Spotted an error? See our methodology for how records are checked and how to report a correction.